AMORPHOUS SOLID DISPERSIONS
Application
US20260091032A1
Kind: A1
Apr 02, 2026
Assignee
INTRA-CELLULAR THERAPIES, INC.
Inventors
Peng Li
Abstract
The disclosure provides new, stable, pharmaceutically acceptable amorphous solid dispersions of 1-(4-fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one, together with methods of making and using them, and pharmaceutical compositions comprising them.
CPC Classifications
A61K 31/4985
A61K 9/0019
A61K 9/0024
A61K 9/0053
A61K 9/1617
A61K 9/1635
A61K 9/1641
A61K 9/1652
A61K 9/2013
A61K 9/2027
A61K 9/2031
A61K 9/2054
A61K 9/4858
A61K 9/4866
A61K 47/38
A61P 3/04
A61P 25/06
A61P 25/18
A61P 25/22
A61P 25/24
A61P 25/28
A61K 9/10
C07D 471/16
Filing Date
2025-08-06
Application No.
19292836